Digital cognitive rehabilitation market seen doubling to $1.15 billion by 2030

The market for digital cognitive rehabilitation solutions is projected to climb from $0.47 billion in 2025 to $0.56 billion in 2026, then reach $1.15 billion by 2030, according to The Business Research Company. Growth is being driven by rising neurological disorders, stronger demand for remote care and wider use of digital health tools.

Why it matters: - Digital cognitive rehabilitation is becoming a bigger piece of post-acute and neurological care. - The market’s projected growth signals rising demand for tools that support memory, attention and executive function recovery outside traditional clinical settings. - The category also reflects broader adoption of remote, personalized digital health services.

What happened: - The Business Research Company said the digital cognitive rehabilitation solution market is expected to reach $0.56 billion in 2026, up from $0.47 billion in 2025. - The report projects the market will hit $1.15 billion by 2030. - The company forecast a 19.4% compound annual growth rate in 2026 and a 19.6% CAGR over the forecast period. - The report was released Sept. 16, 2026, in London. - The company published a free sample of the market report and the full market report.

The details: - Digital cognitive rehabilitation solutions are software platforms or applications based on evidence-based practices. - The tools use adaptive cognitive exercises, interactive tasks and tracking features. - The platforms are designed to support people recovering from traumatic brain injuries, strokes and neurodegenerative diseases. - The software customizes training intensity using real-time user data. - The report says this approach is meant to promote neural plasticity and improve recovery outcomes. - The market’s historic growth is linked to rising neurological disorders, a stronger preference for non-invasive treatment, wider use of digital health technologies, greater awareness of cognitive therapy benefits and higher demand for post-acute care management. - The report says the main growth driver is the rising incidence of neurological disorders. - Neurological disorders affect the brain, spinal cord and peripheral nerves, and can impair movement, cognition, sensation and behavior. - An aging global population, more strokes and traumatic brain injuries, and chronic illnesses such as diabetes and hypertension are contributing to the increase. - Data released in December 2025 by the Australian Bureau of Statistics showed about 2.2 million Australians, or 8.7% of the population, were living with at least one long-term neurological condition in 2023. - That figure is roughly 1 in 11 people. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a shift from clinic-centered rehabilitation toward more continuous, at-home and remote care models. - Personalized training and ongoing progress tracking are becoming central selling points in digital therapy. - The regional outlook suggests mature demand in North America and faster adoption in emerging markets across Asia-Pacific.

What's next: - The market is expected to keep expanding as tailored rehabilitation platforms, analytics and remote care tools gain adoption. - The report expects stronger demand for continuous cognitive performance monitoring, interactive exercises and evidence-based digital protocols. - The company says future growth will also depend on improving rehabilitation outcomes and patient compliance. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated trend analysis.

The bottom line: - Digital cognitive rehabilitation is moving from a niche therapy tool to a faster-growing digital health category with clear demand in neurological care.